Medicaid Provider Spending

$1.09 trillion in Medicaid claims data, 2018–2024 · 617K+ providers

URGENT CARE SPECIALISTS PC

NPI: 1902157746 · WILBRAHAM, MA 01095 · Urgent Care Clinic/Center · NPI assigned 09/19/2012

$1.33M
Total Medicaid Paid
20,311
Total Claims
19,316
Beneficiaries
19
Codes Billed
2018-01
First Month
2024-12
Last Month

Provider Details

Authorized OfficialADAMS, JASON (AUTHORIZED OFFICIAL)
NPI Enumeration Date09/19/2012

Related Entities

Other providers sharing the same authorized official: ADAMS, JASON

ProviderCityStateTotal Paid
CHRISTUS HEALTH ARK-LA-TEX TEXARKANA TX $15.64M
URGENT CARE SPECIALISTS PC HOLDEN MA $367K
CHRISTUS HEALTH ARK-LA-TEX TEXARKANA TX $306K
ADAMS PLASTIC SURGERY, PC FARMINGTON NM $134K
CHRISTUS HEALTH ARK-LA-TEX TEXARKANA TX $91K
CHRISTUS HEALTH ARK-LA-TEX TEXARKANA TX $37K
URGENT CARE SPECIALISTS PC HOLDEN MA $8K
CHRISTUS HEALTH ARK-LA-TEX TEXARKANA TX $2K

Monthly Spending Trend

Yearly Breakdown

YearClaimsTotal Paid
2018 702 $35K
2019 637 $30K
2020 980 $41K
2021 3,210 $268K
2022 3,952 $261K
2023 6,080 $374K
2024 4,750 $320K

Billing Codes

CodeDescriptionClaimsBeneficiariesTotal Paid
87636 Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B 2,962 2,820 $354K
99214 Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity 3,714 3,544 $226K
99213 Office or other outpatient visit for the evaluation and management of an established patient, low complexity 4,588 4,389 $204K
87637 Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV 1,447 1,374 $169K
99203 Office or other outpatient visit for the evaluation and management of a new patient, low complexity 2,397 2,343 $153K
99204 Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity 1,392 1,357 $135K
87651 Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe 1,549 1,501 $40K
87631 170 166 $15K
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe 189 177 $8K
87502 Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets 138 133 $7K
99211 Office or other outpatient visit for the evaluation and management of an established patient, minimal severity 470 412 $6K
87426 Infectious agent antigen detection, SARS-CoV-2 (COVID-19) 263 223 $4K
87804 Infectious agent antigen detection by immunoassay; Influenza, each type 192 119 $2K
71046 Radiologic examination, chest; 2 views 161 121 $2K
G2023 Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source 121 100 $2K
81003 425 413 $701.53
87807 80 72 $651.10
87880 Infectious agent antigen detection by immunoassay; Streptococcus, group A 41 40 $508.40
SPLIT Blood split unit 12 12 $0.00